首页> 外文期刊>Social science and medicine >Determinants for the adoption of angiotensin II receptor blockers by general practitioners.
【24h】

Determinants for the adoption of angiotensin II receptor blockers by general practitioners.

机译:全科医生采用血管紧张素II受体阻滞剂的决定因素。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Results of studies conducted 10-20 years ago show the prominence of commercial information sources in the adoption process of new drugs. Over the past decade, there has been a growing emphasis on practicing evidence-based medicine in drug prescribing. This raises the question whether professional information sources currently counterbalance the influence of commercial information sources in the adoption process. The aim of this study was to identify determinants influencing the adoption of a new drug class, the angiotensin II receptor blockers (ARBs), by general practitioners (GPs) in The Netherlands. A retrospective study was conducted to assess prevalent ARB prescribing for hypertensive patients using the Integrated Primary Care Information (IPCI) database. We conducted a survey among all GPs who participated in the IPCI project in 2003 to assess their exposure to commercial and professional information sources, perceived benefits and risks of ARBs, perceived influences of the professional network, and general characteristics. Multilevel logistic regression was applied to identify determinants of ARB adoption while adjusting for patient characteristics. Data were obtained from 70 GPs and 9470 treated hypertensive patients. A total of 1093 patients received ARBs (12%). GPs who reported frequent use of commercial information sources were more likely to prescribe ARBs routinely in preference to other antihypertensives, whereas GPs who used a prescribing decision support system and those who were involved in pharmacotherapy education were less likely to prescribe ARBs. Other factors that were associated with higher levels of ARB adoption included a more positive perception of ARBs regarding their effectiveness in lowering blood pressure, and working in single-handed practices or in rural areas. Aside from determinants related to the patient population, adoption of a new drug class among Dutch GPs is still determined more by their reliance on promotional information than by their use of professional information sources.
机译:10到20年前进行的研究结果表明,在采用新药的过程中,商业信息资源非常重要。在过去的十年中,在药物处方中越来越重视实践循证医学。这就提出了一个问题,即专业信息源当前是否在采用过程中抵消了商业信息源的影响。这项研究的目的是确定影响全科医生(GPs)在荷兰采用一种新药血管紧张素II受体阻滞剂(ARBs)的决定因素。进行了一项回顾性研究,以使用综合初级保健信息(IPCI)数据库评估高血压患者的普遍ARB处方。我们对参加2003年IPCI项目的所有GP进行了一项调查,以评估他们对商业和专业信息源的了解,ARB的感知收益和风险,感知的专业网络影响以及总体特征。在对患者特征进行调整的同时,应用多级逻辑回归来确定采用ARB的决定因素。数据来自70名GP和9470名接受治疗的高血压患者。共有1093例患者接受了ARB(12%)。报告频繁使用商业信息源的全科医生比其他降压药更倾向于常规开ARB,而使用处方决策支持系统的GP和参与药物治疗教育的GP较不开ARB。与采用更高水平的ARB相关的其他因素包括,对于ARB在降低血压,单手操作或在农村地区工作的有效性方面,他们抱有更积极的看法。除了与患者人群有关的决定因素外,荷兰全科医生中采用新药的类别仍然更多地取决于他们对促销信息的依赖,而不是他们对专业信息资源的使用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号